Literature DB >> 19427581

The impairment of preconditioning-mediated cardioprotection in pathological conditions.

Pitchai Balakumar1, Harsimran Singh, Manjeet Singh, Madhu B Anand-Srivastava.   

Abstract

Myocardial ischemia is a condition in which the blood flow to the heart is diminished and thus the supply of oxygen and nutrients to the heart is reduced. The reperfusion to an ischemic myocardium often results in induction of infarction and cardiac dysfunction. The brief episodes of ischemia and reperfusion given before prolonged ischemia and reperfusion denotes ischemic preconditioning, which protects the heart from lethal ischemia-reperfusion injury. However, it is intriguing to note that the cardioprotective effect of preconditioning is suppressed in some pathological conditions such as hypercholesterolemia, hyperglycemia, hypertension, cardiac hypertrophy, aging, obesity and hyperhomocysteinemia. In this review, we have critically discussed the possible mechanisms involved in the modulation of cardioprotective potential of ischemic preconditioning in various pathological conditions.

Entities:  

Mesh:

Year:  2009        PMID: 19427581     DOI: 10.1016/j.phrs.2009.03.002

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  20 in total

1.  Aging, metabolic syndrome and the heart.

Authors:  Guarner Veronica; Rubio-Ruiz Maria Esther
Journal:  Aging Dis       Date:  2012-03-13       Impact factor: 6.745

2.  Vascular receptors as new substrates for matrix metalloproteinases in hypertension and other inflammatory states.

Authors:  Theodore J Kalogeris; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-16       Impact factor: 4.733

Review 3.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

4.  Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress.

Authors:  T Ravingerová; I Bernátová; J Matejíková; V Ledvényiová; M Nemčeková; O Pecháňová; N Tribulová; J Slezák
Journal:  Exp Clin Cardiol       Date:  2011

Review 5.  Microvascular responses to cardiovascular risk factors.

Authors:  D Neil Granger; Stephen F Rodrigues; Alper Yildirim; Elena Y Senchenkova
Journal:  Microcirculation       Date:  2010-04       Impact factor: 2.628

Review 6.  The role of comorbidities in cardioprotection.

Authors:  Michael N Sack; Elizabeth Murphy
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011 Sep-Dec       Impact factor: 2.457

7.  Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.

Authors:  Lalita Babbar; Nanjaian Mahadevan; Pitchai Balakumar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-17       Impact factor: 3.000

Review 8.  A systematic review and meta-analysis of the cardioprotective effects of remote ischaemic preconditioning in open cardiac surgery.

Authors:  Janine M Pilcher; Paul Young; Mark Weatherall; Ishtiaq Rahman; Robert S Bonser; Richard W Beasley
Journal:  J R Soc Med       Date:  2012-10       Impact factor: 5.344

9.  Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic rats.

Authors:  Wenna Li; Nan Wu; Wenqi Shu; Dalin Jia; Pengyu Jia
Journal:  Exp Ther Med       Date:  2015-10-01       Impact factor: 2.447

10.  Diesel Exhaust Worsens Cardiac Conduction Instability in Dobutamine-Challenged Wistar-Kyoto and Spontaneously Hypertensive Rats.

Authors:  Mehdi S Hazari; Jarrett L Lancaster; Joseph M Starobin; Aimen K Farraj; Wayne E Cascio
Journal:  Cardiovasc Toxicol       Date:  2017-04       Impact factor: 2.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.